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1. Introduction 
Obesity is becoming increasingly common, with at least 400 million obese adults worldwide 
and the World Health Organization (WHO) projecting that this statistic will reach 700 
million in another five years [1]. The body, which is altered by excessive weight, has its 
biological process modified. This results in several diseases. Different diseases such as heart 
disease and strokes, high blood pressure, type 2 diabetes, cancer, asthma, sleep apnea, 
osteoarthritis are all related to obesity [2]. 
According to a recent survey by the Brazilian Society of Endocrinology and Metabolism 
(SBEM) obesity in Brazil has increased, on average, 240% over the past 20 years. Today, 
methods of treatment for obesity are: a) diets; b) non-pharmacological treatments; c) 
pharmacological treatments; d) surgeries. All the aforementioned methods have the same 
principle –an energy deficit is necessary to cause weight loss. 
Among the techniques available for treating obesity, surgical techniques are more efficient. 
It is known that surgical methods offer effective results, maintaining 50% weight loss for 10 
years. Two types of surgical treatments are practiced: a reduction of the stomach volume to 
diminish food ingestion and the use of a stomach-intestine bypass to produce practically no 
absorption of nutrients [3]. 
In type 2 diabetes mellitus (T2DM), treatment with pharmacologic therapies in order to control 
blood sugar only slows progression of the disease. Bariatric surgery has been implicated in the 
complete resolution of type 2 diabetes mellitus in several clinical studies [4].  
Multidisciplinary studies for treating obesity and type 2 diabetes mellitus have been 
developed. Doctors and Engineers are working together to deal with the problem and find 
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solutions. This is being carried out especially with biomaterials and in biomedical 
engineering where new devices are being developed.  
GI Dynamics® is developing a novel endoscopic treatment for obesity and T2DM. The 
EndoBarrier™ gastrointestinal liner is a removable implant that resides in the proximal 
intestine [3]. Toga, from Satiety, Inc., still in its trial stages, inserts flexible stapling devices 
through the mouth and into the stomach, and then uses suction to gather stomach tissue and 
staple it together, creating a small stomach pouch near the esophageal junction and thereby 
increasing satiety [1]. Furthermore, the methods used neuroregulation activation and gastric 
implants for activation of the vagus nerve as a way to control hunger [1,4].Thus, it is worth 
noting that there are difficulties in proposing an efficient obesity treatment. In other words, 
the control and cure of the multiple causes of obesity associated with eating habits is a 
difficult problem. 
In this study, we designed an esophageal flow control module (CFE) made from a 
biosynthetic material based on natural latex (extracted from the rubber tree Hevea brasiliens). 
The intended purpose of the CFE is to help to control the speed and the volume of food 
ingested, and, as a result, to help in treatments to reduce weight. 
The CFE proposed is classified as a restrictive surgical procedure. It is inserted into the 
esophagus (3 cm after the passage of the upper sphincter) and filled with gas. Experimental 
animal research has shown satisfactory results. The device has the mechanical characteristics 
necessary for use inside the esophagus. Furthermore, the animals did not have problems 
with gastric and behavioral changes, nutrition, blood disorders or irritation because of the 
CFE. Therefore, this unprecedented technique, which can solve the obesity problem, allows 
a decreased food intake by decreasing the flow through the esophagus. 
Therefore, even though the device needs to be tested on humans, the efficiency of this 
procedure has been ratified, especially given the success of the evaluation in dogs. Weight loss 
was confirmed (and validated) between two groups of animals tested. One group had the 
module and the other did not (however both maintained the same dietary and environmental 
routine). A biomaterial, latex, is used in its development, given its prominence (in Brazil). There 
are non-gummy, rubber, hydrocarbon particles in the composition of natural latex. The particles 
are suspended in an aqueous solution phase in which there is on average 36% hydrocarbons, 
1,4% proteins, 1,6% carbohydrates, 1% neutral lipids, 0,6% glycolipids plus phospholipids, 0,5% 
inorganic components, 58,5% water and 0,4% of other substances. For this reason, Hevea 
brasiliensis latex is a complex cytoplasmic system in which the rubber particles and the non-
rubbery particles (also called non-gummy) are dispersed in an aqueous cytosolic phase. It is a 
national low-cost product, which is also easy to handle. Latex, plus other substances, was 
initially used as a material that induces healing in damaged esophageal walls. Results showed 
that a natural latex biomembrane with polylysine has biochemical characteristics that make it 
capable of interfering in the process of tissue repair thus promoting the rapid and regular 
formation of new tissue. It is also easy to handle, dispensing with complex techniques for 
manufacturing and use [5, 6, 7]. Based on these data, other studies utilizing latex have been 
done, such as using latex for myringoplasty in humans [8] and applying latex biomembranes 
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for treating ischemic leg ulcers. Here, the goal is for the biomembrane to act as an inducing 
agent for healing tissues [9]. In [10], this membrane was employed in recurrent umbilical 
hernias and its effectiveness was established in twelve dairy cows. 
In orthopaedic research aimed at more effective bone regeneration, latex was efficient in 
repairing tibial fractures in a rabbit, demonstrating great potential for this kind of 
application. In skull fractures in rats, the results were similar and the researchers believe 
that new investigations indicate its use in osteoporosis, odontology and facial bone 
reconstruction [11]. In [12], they developed a new microperforated vascular prosthesis 
model, made of tissue covered with a compound derived from rubber tree natural latex 
(Heveabrasiliensis) and used an expanded a polytetrafluoroethylene prosthesis as control in 
the contralateral pelvic limb in the same animal. The study was done applying two 
prostheses in 15 dogs. The microperforated latex and fabric graft showed satisfactory 
structural qualities (adaptability, elasticity, impermeability and possibility of suture) as a 
vascular substitute. It stimulated endothelial growth, beyond contact regions with the artery 
in anastomoses and was bicompatible with the dog’s arterial system, showing adequate 
tissue integration. In [13], they evaluated using a natural latex mould in the postoperative 
surgical preparation of the neovagina with the objective of inducing healing and to keep the 
cavity functional in nine patients with Mayer-Rokitansky-Küster-Hauser (MRKH) 
syndrome. The results confirmed the properties of tissue replacement and regeneration of 
natural latex derived from Hevea brasiliensis and acceleration of the healing process with no 
rejection. In [14], they developed a topical latex membrane for controlled drug release. In 
other medical areas, latex has been studied and successfully utilized in the healing process 
of ulcers, and in burned areas on the body’s surface and in conjunctiva reconstruction [8]. 
Due to these promising results, using latex was the basis for making the new device 
proposed here for treating and controlling diabetes and obesity.  
A study was conducted concerning esophageal diseases in order to propose a device and its 
placement technique. It was found that patients with obstructive diseases of the esophagus 
(caustic stenosis, chagasic megaesophagus and esophageal cancer) have high weight loss as 
a result of reducing the flow of food,which can be seen in [15,16,17,18]. Because these 
esophageal diseases cause a reduction of the esophageal lumen or obstruct the emptying of 
the organ, they lead to the patient losing weight. In this context, the CFE® module was 
developed for helping in the treatment of obesity and it also can be used for diabetes 
treatment due to the significant weight loss achieved with its use. This chapter describes the 
engineering and design used in the development of the device and the tests already carried 
on it aiming at its efficacy and security evaluation in order to offer to the global community 
a new option for obesity and diabetes treatments.  
2. Materials and methods 
Whereas a decrease in food consumption may be secondary to esophageal obstruction and 
considering that there is the possibility for inserting devices that may alter its diameter 
(which takes place in the treatment of bleeding due to esophageal varices), it was plausible 
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to suppose that developing the CFE® module may lead to reducing food intake.The 
objective is to evaluate the possibility of CFE® insertion into the esophagus which causes, 
during its use, resistance to the passage of food bolus. This makes food ingestion slower due 
to a reduction in the lumen of the esophagus, resulting in the need for prolonged chewing.   
2.1. Latex preparation  
The latex used here had already been through the centrifuging process, with sulfur and 
resin suspensions, having the objective of providing elasticity and the necessary strength for 
the final compound. From this preparation process, the latex is configured as a compound 
which upon contact with the skin, vulcanizes, making it adhesive. To be removed, however, 
just pure water is used. On glass surfaces, its removal is facilitated due to the low friction 
that glass provides. 
When handling the latex, glass rods were used for mixing, as well as a glass container for 
storage, plastic wrap to protect it from contact with the air and cotton flannel for cleaning. 
An important point for any application that uses raw latex is the uniformity of its properties, 
since this is an essential characteristic. To obtain this characteristic, the latex source should 
be the same, i.e. the latex should come from trees of the same clone. 
2.2. Manufacturing the CFE® module 
The CFE® module was manufactured aiming to develop a mechanical device, with 
biocompatible and flexible material, in the shape of an 8 cm long cylindrical balloon, 
inflatable with gas by a valve system with an approximately 1 cm diameter conduit. The 
dimension established for length refers, approximately, to the size of the upper third of the 
esophagus. Incorporated into the module were radiography visualizations and fixing 
devices, containing within them a barium contrast indicator for controlling the position for 
x-rays. At one of the ends, there is a thread for fixing the module to a dental crown, which 
should be attached to the superior molar with the aim of preventing the module from 
migrating to the stomach in the event of accidental disinflation. 
Manufacturing the CFE® module begins with preparing the environment, the raw material 
and the moulds and then follows a series of steps, such as: immersion of the glass moulds into 
a container containing liquid latex, drying the moulds in an oven, analyzing the thickness, 
removing the solidified latex from the moulds, assembly of module and final inspection.  
2.3. Cadaver test  
An experimental feasibility study was conducted, testing the placement and removal of the 
CFE® device in the esophagus of a cadaver at the Institute of Forensic Medicine (IFM). After 
being applied, the module was inflated with the aid of a manometer adapted to a pressure 
of 120 mm Hg. Its placement was made with delicate maneuvers aimed at preventing 
alterations to the module to be examined. 
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2.4. In-vitro study 
With the objective of estimating the minimal time to carry out an intervention, in the event 
that it descends to the stomach and in order that it not cause intestinal obstruction, an 
experiment was conducted in the Laboratory of Engineering and Innovation – LEI at the 
Gama Campus of the University of Brasília. This experiment compared the volume of BIB 
(400 ml to 700 ml) and (CFE 146 ml) with the goal of comparing its volumes and its 
emptying capacity in the case it is punctured. The calculation employed for obtaining the 
CFE volume used a technique based on solids of revolution and the time was obtained from 
simple arithmetic means. There were four CFE modules used as samples and these were 
immersed into an environment similar to the stomach. The method utilized was to inflate 
the CFEs with the same pressure to be applied in humans (60 mmHg – minimum), 
withdrawal of the scalp1 number 27, immersion of the CFE in the environment with the hole 
made in the sample by the scalp on the upper part of the module thereby forcing partial 
emptying, since if it were not punctured, it would not empty as in the test done in [7].  
2.5. Preparation for clinical trial 
The choice for using a dog – as an animal for testing and for weight loss and/or as a validator 
of the CFE module – was made in light of findings raised with medical veterinarians. It was 
verified that the animal would be an excellent subject for analysis in this study keeping in 
mind the anatomical-physiological similarity between human and canine esophagi. Allied 
with this, above all, factors that denote affability with such animals and also, the facility of 
controlling their eating routine, as well as the food ingestion speed of the animal, associated 
with little chewing and the absence of psychological pressure (as opposed to what a human 
develops when the goal is losing weight). To conduct the experimental procedure, eight adult 
dogs, of no specific breed, males and females, with body weights varying between 9.2 and 17.8 
kg were selected. Before the experiment, the animals were kept at the Veterinarian Hospital 
kennel at the Federal University of Goiás to be submitted to quarantine procedures that 
include: vaccination (Duramune Max, single dosage), application of ecto and endoparasiticides 
(administered through 100 mg of mebendazole, twice a day for three days), in addition to 
laboratory exams like blood count, urinalysis, hormonal and blood biochemical evaluations. 
Furthermore, improvements in the nutritional conditions of the animals was sought, through 
the implementation of a daily diet of dry dog food, supplemented with semi-moist dog food 
rich in nutrients (Dudog®). The animals were vaccinated against rabies and DHLPPC 
(distemper, hepatitis and adenovirus, leptospirosis, parainfluenza, parvovirus, and 
coronavirus) and dewormed with a broad spectrum dewormer. Ectoparasites were eliminated 
with a two-dose application of pour-on parasiticide. Blood was taken from all the animals and 
when hemoparasitoses was present, doxycycline was applied for 21 days, and diminazene in 
two applications with an interval of 15 days. 
                                                                 
1 The scalps peripheral intravenous comprise: siliconized needle stainless steel bezel with thin walls and biangular and 
three faceted; wings malleable and flexible, adjustable anatomically as handling (known as "butterfly"); transparent 
vinyl tube. 
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2.6. Experimental model for analyzing weight loss 
It has been suggested that application is the placement and utilization of the CFE® module 
in the upper third of the esophagus (3 cm after the passage of the upper sphincter) of the 
dogs through video-endoscopy over a period of seven days as a weight loss method. The 
research protocol was previously submitted and approved by the Ethics Committee for 
Human and Animal Medical Research at the Federal University of Goiás (UFG) (process 
number 060/2008, registered on SAPP-WEB number 33256). To conduct the experimental 
procedure, eight adult dogs, of no specific breed, males and females, with body weights 
varying between 9.2 and 17.8 kg were selected. Before the experiment, the animals were 
kept at the Veterinarian Hospital kennel at the Federal University of Goiás to be submitted 
to quarantine procedures in addition to laboratory exams like blood count, urinalysis, 
hormonal and blood biochemical evaluations. 
2.6.1. Plan for placement 
The technique proposed for this new method is based on the mechanical decrease of the 
esophageal lumen, which directly influences a decrease in the speed and volume of food 
consumption, without altering the digestive tract or bringing about physiological and 
nutritional alterations: the outcome of the technique is weight loss. To achieve this, the CFE 
module was tested experimentally on animals, with the objective of verifying its capacity for 
accomplishing weight loss in the animal. 
2.6.2. Definition of the groups 
For this experiment, six dogs of no special breed, males and females, with body weight 
varying between 9.780 to 18.100 kg were selected. The process for recruiting and handling 
the animals followed the same norms described in the previous experiment. At this point, 
note that the animals were divided into two groups – the weight control-group (GCp) and 
the test-group (GT). In the weight control-group, the animals received the same dietary 
treatment and the same routine as the test-group; however, the module was not placed in 
the subjects in the first group. In the test-group, the module was placed following the same 
steps as the previous experiment, as shown in Table 1.  
 
Groups 
(n=2) 
Weight (kg) ݔ Sex Pressure applied (mmHg) F M 
GC 12.84 1 1 60 
GT1 11.56 1 1 100 
GT2 12.10 0 2 120 
GT3 14.63 0 2 140 
Table 1. Group Distribution. 
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2.6.3. Video-endoscopy placement 
The video-endoscopy procedure was conducted according to the same steps as described in 
the previous experiment.  
2.6.4. Post-placement care 
The post-placement period and the routine of the animals were carried out similar to the 
previous experiment. 
2.6.5. Evaluation parameters 
The parameters used in the evaluation were volume, speed, ingestion time, nutritional, 
hormonal and complete blood count, in addition to weight loss.  
2.6.6. Volume, speed and ingestion time 
The same diet (nutritional, quantity, and schedule characteristics) was chosen for evaluating 
the behavior of the dogs while eating, as well as for measuring the food left over (which was 
weighed and recorded). Another point evaluated was the time spent eating in both groups – 
which is approximately proportional to the volume ingested – through clinical observation, 
a timer and a precision scale. 
2.6.7. Nutritional, hormonal and complete blood count 
The nutritional, hormonal and complete blood count was investigated by blood tests done 
before and after the placement. The tests done were classified as nutritional and blood count 
tests.  
2.6.8. Weight loss 
Weighing of the animals was done before the placement and after every two days until the 
module was withdrawn. Weights in the beginning and in the end of the experiment were 
compared, and comparisons were also made between the control and test groups.  
2.7. Evaluation instruments 
2.7.1. Clinical observation 
Clinical observation was one of the evaluation instruments used, in which a daily chart was 
filled out with data referring to the following data bases: 1) reaction of dog before and after 
meals; 2) reaction of dog during ingestion of water; 3) stool consistency; 4) amount voided; 
5) behavior (irritated, agitated, normal); 6) gagging, cough, vomit, choking; 7) signs of 
dysphagia; 8) behavior in the presence of other dogs; 9) blood tests; 10) weight at the end of 
the day. 
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2.7.2. X-rays 
Radiographic follow-up of the animals was done of the cervical region on the lateral-right 
(in decubito) side, immediately after placement of the module, and every two days until its 
removal. The test was done in the radiology laboratory at the Veterinary School at UFG, 
according to the following protocol: 55 kV, 300 mA, 0.04 second of exposure in a right-lateral 
ducubitus position. A normal esophagus is not visible radiographically, because it is a close 
to collapsing organ and the module behaves like a foreign body (filled with gas), making it 
possible to visualize it radiographically. Thus, due to the radiopacity of the gas, it is possible 
to determine location by means of image. 
2.7.3. Video-endoscopy 
A video-endoscopy was performed on the 15th day, after withdrawal of the module. The 
procedure was analogous to that used during placement, utilizing the same endoscopic 
material.  
2.8. Exclusions 
There were no exclusions of the dogs, including those that expelled the modules. All of 
them, at the end of the experiment were evaluated. 
2.9. Statistical study 
The statistical hypothesis t-student test was used here to make a comparison between the 
groups (small samples). All discussions of the present study were carried out with a 99% 
confidence interval.  
3. Results 
In Figure 1, the CFE module developed with its morphological macroscopic appearance can 
be observed. 
 
Figure 1. Picture of the esophageal flow control module – CFE; from left to right: upper and side views 
The materials used in the manufacturing and packaging of the module that did withstand 
high temperatures, were sterilized with ethylene oxide. The materials (moulds) that 
withstand high temperatures were sterilized by steam autoclave.  
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3.1. Cadaver test 
In this study, a guide needed for pulling the device through to the inside of the esophagus 
was developed. During the removal procedure, the external wall of the module was 
perforated for deflation and it was removed with endoscopic forceps.  
3.2. In-vitro study 
It was found that if the module is inflated with the volume and pressure as described 
above,upon reaching the stomach it would take, via simple arithmetic mean, 49 hours to 
partially empty. With this partial emptying, it could pass through the pylorus and into the 
intestine, a situation similar to what occurred in the experiment presented in [7]. On that, 
note that among the restrictive techniques already in practice, endoscopic intervention is 
done to remove the object from the stomach before it descends into the intestine. In the case 
of the CFE – in the event that it becomes lodged in the stomach between one radiography 
and another, meaning during a 24-hour period, we would have ample time for removing it 
endoscopically without causing intestinal obstruction. It is worth mentioning in a detailed 
analysis carried out, it was noted that studies apply synthetic prosthesis in patients as 
temporary substitutes for the esophagus, and they are made of diverse materials such as: 
silicone, Marlex®, Teflon®, collagen, and a mixture of collagen and silicone. The amount of 
time the prosthesis remained inside the body was on average from four to five weeks, from 
its placement until its exit which corresponds to the end of this treatment, when expelled in 
the feces after this period without causing intestinal obstruction. In [6], which is used as a 
basis for this work, among the groups evaluated, cases occurred where the latex prosthesis 
was expelled by the animal, without causing intestinal obstruction. Thus, the scope of 
radiographic evaluations adopted (every 24 hours) was done to prevent the possibility of it 
passing from the stomach to the intestine. 
3.3. Weight loss analysis experiment 
This analysis sought to verify if the diet offered was bringing about weight loss in the 
animals. Considering this, the food provided was initiated ten days before placing the 
module: the animals accepted the food well given that the ingredients used were appealing. 
With this procedure, weight loss did not take place in any dog. On the contrary, some 
animals experienced weight gain.  
3.3.1. Volume, speed and ingestion time 
The food provided was semi-moist, made for each dog individually with measurements 
calculated according to the animal’s weight, as indicated by the manufacturer. When 
preparing the food, solid dog food was used along with meat pâté for dogs and a dietary 
supplement called Dudog®. With the assistance of a veterinary doctor plus the 
manufacturer’s instructions, the dietary composition was established for each dog which is 
presented in Table 2.  
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 Dog weight (kg) Solid dog food (g) Meat (spoonful) Dudog® (slices) 
GCp 
13,100 331 2 4 
13,400 339 2 4 
15,780 410 3 6 
GT1 
9,780 247 1 2 
10,120 256 1 2 
18,100 470 3 6 
 
Table 2. Amount of food offered to each dog, mixed with 1 liter of water. 
The containers used were identified with name of each dog, being “deducted” from their 
weight at each meal offered. All meals provided were weighed after having been mixed 
with water in a blender. During feeding, the dog was monitored. When done eating, the 
container was removed and weighed again, so that the exact amount of the volume 
ingested, per meal per dog, was obtained.  
However, it was observed that the volume of food ingestion in group GT1 was less than the 
volume in group GCp. The accumulation of leftovers was observed in the feeding of all 
subjects in group GT1, having at times volumes up to 1 kg. This fact indicated that the 
method restricted the volume of food consumed by the dogs, but without causing apparent 
discomfort. Another point that should be put forth is that in the observation, there was great 
care taken to verify if there was evidence of satiety after eating in the dogs with the module. 
To this end, the container was left longer to confirm the dog’s level of satiety. Faced with 
this situation, the animals did not go back and enjoy the rest of the contents, even when it 
was offered directly to them. This fact is a strong indicator that the dogs felt satiated. The 
speed and the time for ingesting the food were two other items observed, given that in the 
first two days, it was clearly noted that in group GT1, both (time and ingestion) were greater 
than those in group GCp. 
During the eating process, the dogs in group GT1 made pauses in their food ingestion. This 
decreased and later it normalized over the subsequent days. It is believed that this situation 
occurred due to the esophagus module accommodating itself. After, it was observed that 
there was an inversion, since the food ingestion time of group GT1 was reduced and the 
amount of food consumed became gradually less. It must also be put into evidence that each 
dog was offered two meals a day – one at 09:00 and another at 18:00. 
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3.3.2. Nutritional, hormonal and complete blood count 
The complete blood count was collected through the Vacutainer® system, taken from the 
arteriovenous group in a tube with four drops of anti-coagulant (10% EDTA solution), 
then performing the homogenization of the samples with slow and regular movements. 
From the samples, hemoglobin, hematocrit (the percentage occupied by red blood cells 
or erythrocytes in total blood volume, because a decrease in it may indicate anaemia), 
and total plasma protein (TPP) were evaluated. The data collected was analyzed 
statistically following the Tukey test (p<0,05), in the ANOVA module of STATISTICA 
software, with repeated measurements and a non-parametric test, for qualitative 
variables. The data obtained from the blood count are described in Table 3 below, thus 
allowing evaluation of the effects of the esophageal module, as well as evaluating how it 
affects the blood tissue. 
 
 
Hemoglobin (g/%) Hematocrit (%) TPP*(g/%) 
Average DP() Average DP() Average DP() 
GCp 8,16 0,83 30,19 3,02 7,21 0,37 
GT1 8,08 0,95 30,25 3,36 7,33 0,54 
Table 3. Evaluation of the hemoglobin, hematocrit and total plasma protein. Values do not differ (p > 
0,05). *TPP = Total plasma protein. 
It was also verified that the average values obtained from the evaluation do not differ. 
Therefore, it may be suggested that the method does not promote alterations in the blood 
tissue, since when the hemoglobin concentration was evaluated, there was no difference 
between the groups (p > 0,05), considering that the same result was obtained in the 
hematocrit and TPP evaluations. 
However, it is known that blood count evaluations may suffer variations according to the 
nutritional condition of the animals, climatic factors, infections and release of blood 
components. Nevertheless, in this study the parameters were maintained within the 
physiological values.  
3.3.3. Weight loss 
Specifically in relation to weight loss, in all of the experiments conducted in this study 
which involved dogs, the animals’ weights were monitored. Weight loss took place to a 
slight extent (≈1,3%), as well as to a great extent (≈6,3%), for the weight of the dogs in the 
analysis presented in item 7.3 of this study, which used the module. Lower indices were 
observed in recently arrived dogs from the Center for Zoonoses, and the higher indices were 
exhibited in the dogs that had already been at the Veterinary Hospital for a longer period of 
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time. It is believed that this occurred because the dogs that had recently arrived were under 
their ideal weight.  
In this analysis in which the two groups GCp (without module) and GT1 (with module) 
were compared, it was observed that the group in which the module was applied (for seven 
days), weight loss took place. This fact is attributed to a decrease in the volume of food 
ingested, brought about by the module placed in the esophagus. In Table 4, data related to 
the dogs submitted to the test are presented. For ten days, semi-moist food, before the 
module’s placement, was provided to the two groups and after the module’s placement, the 
dogs remained for seven more days on the same dietary routine.  
The data in Table 4 are described next. In the Start column, the original weight of the dog is 
presented. The GCp lines correspond to the weights of the dogs in the control group that 
did not use the module and the GT1 lines are of the dogs in which the module was placed. 
The dogs were fully fed over a period of 10 days without the module. The weight of the 
dogs at the end of 10 days is shown in the “10 days (final)” column. Then, the modules were 
installed only in group GT1, and remained in the dogs for a period of 7 days, and the final 
weights, after 7 days, are presented in the “7 days (final)” column. The column furthest to 
the right indicates the weight loss percentage in relation to the weight of the dogs in both 
groups on the date of the module’s placement.  
 
 
 
 
Dog weight 
(kg) 
Start 
Dog weight 
(kg) 
10 days (final) 
Dog weight (kg)
7 days (final) 
Weight change (%) 
GCp 
13,100 13,480 14,000 (+) 3,71 
13,400 13,400 13,590 (+) 1,39 
15,780 16,200 16,630 (+) 2,58 
GT1 
9,780 9,900 9,540 (-) 3,63 
10,120 12,180 11,140 (-) 8,54 
18,100 19,800 17,950 (-) 9,35 
 
 
 
Table 4. Animal weight variation2. 
                                                                 
2 The values shown in the table are an average of the weights.  
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3.4. Clinical trial 
After placing the module, the animals were evaluated over a period of 15 days. No dog died 
and there was no exclusion. At the end of the procedures associated with the experiment, 
the dogs received hygiene care, food and the necessary clinical-laboratorial evaluations, in 
order that they be donated to owners registered in the Veterinary Hospital data bank (which 
in fact did take place).  
3.4.1. Lack of appetite 
No grave alteration in appetite was observed, such as anorexia. However, all of the groups 
ate less than what was observed before placing the module, thus characterizing a state of 
hyporexia. The semi-moist food provided was of the same consistency and quantity, and 
accepted by all of the animals, who also did not show any clinical manifestation suggesting 
dysphagia. None of them had clinical alterations during the period following. 
3.4.2. Absence of voiding and/or defecation 
In all groups, voidance was normal, present and without difficulty. But defecation took 
place with less frequency, was not daily, and had a soft consistency.  
3.4.3. Range of pressure values 
Concerning the range of pressure values, based on the results observed here and in the pilot 
study in dogs, a pressure range from 60 mmHg up to 120 mmHg is suggested for modules 
with construction characteristics similar to those applied in this experiment. As such, an 
exact definition of applied pressure should be made based on the diameter of the dog’s 
esophagus, since the greater the diameter, the greater the pressure must be. This fact must 
be taken into consideration and evaluated prior to the endoscopy because there is a 
reasonable dimensional variation, given the vast number of breeds that are found in this 
species, each having distinct anatomical features. 
Clinical observation shows that the expected outcome was achieved with the placement and 
fixedness of the module for GC and GT1, while preserving the dog’s welfare and only 
minimally altering its physical condition. In groups GT2 and GT3, which used greater 
pressure, the dogs’ state remained normal after a long period of adaptation, which altered 
the condition of the animal for a longer period.  
3.5. Damage to the esophageal wall 
The esophagus was analyzed in all of the animals, including the dog belonging to group 
GT3 that expelled the module 20 hours after placement, and one dog in group GT2 in which 
the module descended to the region caudal region of the stomach 9 days after placement. It 
must be emphasized that in all groups, there was no visible alteration to the esophageal 
wall. This finding was made after endoscopic macroscopic evaluation of the dogs’ 
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esophageal wall, after removal of the module, which was compared with the endoscopy that 
had been previously done. Nonetheless, after the endoscopic exam, it was observed that the 
entire esophageal wall was intact, i.e. a normal appearance of the esophageal wall was 
preserved having a bright and rosy coloring, without food residuals or ulcerations. The 
folds were normal as was the frequency of the peristaltic waves.  
4. Discussion  
At this point, it needs to be restated that obesity is a disease that affects an individual as a 
whole. It interferes with mental, physical and social aspects, and is not a direct result of 
psychological disorders, but it is a target for prejudice and discrimination [19 ]. Hence, 
when obese people seek out a doctor for treatment, they are in search of not only a 
healthy body, but also to “discover themselves”. However, there are many problems that 
these individuals face. Standing out from these issues are marital problems, mental 
disorders, anxiety, depression, excessive eating, low self-esteem, guilt complex and no 
self-acceptance [20].  
There are many factors that cause obesity as already described in this study. But in general, 
the main cause of obesity remains to be an altered or inadequate eating behavior. From this 
point of view, it is of fundamental importance that those who are obese are not only seeking 
solutions in order to control their weight: it is essential to provide conditions for re-
educating such people. 
When researching currently available treatments for all ranges of obesity, one point in 
common was observed – decreasing food intake -  because depending on how the 
treatments are carried out each technique in its own way, seeks to achieve this goal. 
However, the failures, having unfavorable consequences to the patient, amongst other 
drawbacks, point to the need for finding new techniques.  
In light of such a necessity, a new device was designed in this study for treating such cases. 
The device presented in this study is called an esophageal flow control module (CFE). It 
must be emphasized that this is a totally original method using a natural raw material 
extracted from the Heveabrasiliensis. An extremely simple, handmade method is used for 
manufacturing it, which is based on observations and products that already exist in this 
surgical field.  
In this sense, it is important to consider that in terms of the surgical procedures utilized 
here, the method (proposed here) qualifies as a restrictive technique. This is particularly 
because the objective of the procedures is to reduce the volume of food ingested. 
Acknowledging that the esophagus is the organ for placement, it should be pointed out that 
this technique has disadvantages and restrictions for placement, which have also been 
described in this study.  
The basis for this proposal then is founded upon presenting a proposal for reducing food 
intake, however, with some significant differences that are listed here: 1) the organ for 
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placement is the esophagus – in its upper third; 2) reduction of the lumen in the esophagus 
works mechanically, which blocks the quantity of food going from the mouth to the 
stomach, limiting the ingestion speed of solid foods; 3) placement takes place by means of 
endoscopy; 4) no alteration to the digestive tract is made, which neither brings about 
dysfunction nor compromises the absorption of nutrients; the procedure does not cause 
esophageal lesions, compared to the “gastric band” method which causes lesions in 10% of 
cases; 5) similar to the other methods, there is the necessity for chewing correctly, however, 
upon ingesting food of improper consistency, the food comes back up (before reaching the 
stomach), a positive point in this treatment, since in the other methods, vomiting crises 
triggered by incorrect mastication may develop into  anorexia and bulimia; 6) similarly to 
the other methods, multi-professional treatment, dietary planning and exercise are also 
necessary. 
In this study, the results show that placing a module inflated with gas in the esophagus, 
does not lead to behavior alterations in the animals. In humans, this feature had already 
been observed in studies that use esophageal balloon applications. In [21], short esophageal 
balloons are used (3 cm length and 1 cm in diameter) and long balloons (16 cm in length and 
0,8 cm in diameter) for measuring the pressure of the esophageal wall. In [22], notations on 
the pressure inside the esophagus with a long balloon led to reports that the best results are 
reached when measurements are made at the middle third, showing that in this region the 
shape of the pressure versus volume curve is not affected by changes in body posture. 
Another application to be shown is aimed at tubular prostheses used to maintain patent 
malignant strictures of the esophagus and seal tracheo-esophageal fistulae, when they are 
fully expanded, reaching 18 mm to 25 mm in diameter and 8 cm to 14 cm length [23]. In the 
procedures that are involved in this study, no macroscopic damage was observed in the 
esophageal wall where the module was placed, or in the entire length of the esophagus. A 
great advantage of this module in relation to the other BIB® methods and the gastric band is 
how simple it is to manufacture, with the raw material "latex" estimated to be low-cost, easy 
to handle and highly biocompatible. 
As for flow control in the esophagus, there are no reports in literature of studies with this 
objective. This may be because no one correlated a common denominator between 
esophageal illnesses that reduce the diameter of the esophagus and marked weight loss. To 
this end, the model presented in this study seeks to promote a reduction in the esophageal 
lumen to achieve weight loss.  
So, mainly based on the results obtained and in the experiments conducted in dogs, a 
new procedure is revealed here for treating cases of obesity, derived from a natural 
source, which imbues it with a low-cost. But, it is probable that alterations and 
improvements will take place in the module aiming at obtaining better results for 
applying it in humans. 
Thus, the results reached suggest the possibility of controlling the volume of food intake 
by means of a mechanical system placed in the esophagus. In obtaining results associated 
with weight loss – without causing significant harm or nutritional changes or alterations 
 Practical Applications in Biomedical Engineering 184 
in the blood, and furthermore without altering the digestive tract –, through a minimally 
invasive procedure, is a fact that is appealing within the current context of society. But, in 
validation of the conclusions reached in the experiments that support this study, it was 
revealed that a desire such as this has not yet been achieved from the scientifically proven 
premises.  
5. Conclusion  
The effects of mastication exert an influence on the mechanisms that trigger satiety. It 
implies nutritional re-education in individuals with obesity and also weight loss, as 
observed in previous studies. One can read in studies by many authors that new studies 
regarding procedures for treating obesity are necessary, particularly with the goal of 
improving the results and decreasing the costs and morbidity of obese patients. But, the 
basic, necessary characteristics for comprising a new treatment should be founded. On a 
minimally invasive procedure, without side effects, that would not interfere or modify 
gastro-intestinal anatomy.  
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